Rology key facts
- Developer of an FDA-cleared AI-assisted teleradiology platform designed to improve diagnostic imaging and streamline access to high-quality radiology reporting.
- It has raised $4.8M; the latest was Accelerator/Incubator in Aug 2025.
- Notable investors include Impact Assets, DeveloPPP Ventures, MIT Solve, African Union Development Agency-NEPAD, Johnson & Johnson Services — 23 tracked in total.
- Status: Privately Held (backing).
Who backs Rology
23+- ·The complete investor list: 23 names
- ·Watch Rology: the Monday email on marks, rounds and moves
Rology funding rounds
No funding rounds for Rology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Rology investors
23 investors are on record for Rology, including Impact Assets, DeveloPPP Ventures, MIT Solve and African Union Development Agency-NEPAD.
About Rology
Developer of an FDA-cleared AI-assisted teleradiology platform designed to improve diagnostic imaging and streamline access to high-quality radiology reporting. The company offers integration with hospital systems, a network of sub-specialized radiologists, and multiple AI models, enabling healthcare providers across the Middle East and Africa, faster reporting, greater accuracy, and reduced operational costs.
- Sector
- Healthcare
- HQ
- Cairo, Egypt
- Founded
- 2017
- Employees
- 60
- Website
- rology.health/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Rology doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.